STTR Phase I: Minimally-invasive reversible thermal nerve block for relief of severe pain
Award amount
$225,000Program and phase
STTR · Phase IAward year
2019Award details
- Awarding agency
- National Science Foundation
- Branch
- Not reported
- Recipient company
- Thermaquil, Inc.
- Proposal award date
- 2019-07-01
- Contract end date
- 2020-06-30
- UEI
- S8FTDLJNX2K5
- Solicitation number
- Not reported
- Topic code
- MD
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Drug Free Nerve Block Device for the Relief of Pain and Symptoms in Migraines and other Headaches
- SBIR Phase II: Drug Free Noninvasive Occipital Nerve Block Device to Reduce Opiate Prescriptions
- Customer discovery for minimally invasive nerve block device to treat severe pain and reduce usage of opiates
Research funding history
4 SBIR/STTR records share this UEI (2019–2021). Reported award amounts total $3,454,995. Reported amounts are not federal obligations.
Phases: Phase II, Phase I
Agencies: Department of Health and Human Services, National Science Foundation